LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000546.5:c.63C>T
TP53
· NP_000537.3:p.(Asp21=)
· NM_000546.5
GRCh37: chr17:7579850 G>A
·
GRCh38: chr17:7676532 G>A
Gene:
TP53
Transcript:
NM_000546.5
Final call
Benign
BA1 stand-alone benign
BP4 supporting
BP7 supporting
Variant details
Gene
TP53
Transcript
NM_000546.5
Protein
NP_000537.3:p.(Asp21=)
gnomAD AF
0.0002397763574315801 (v4.1)
ClinVar
Benign
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Benign: BA1 is met by the South Asian gnomAD v4.1 filtering allele frequency of 0.0037098.
2
Benign: BP4 supporting is met because maximum SpliceAI delta is 0.004, below 0.1.
3
Benign: BP7 supporting is met because the synonymous variant is outside the core splice motif with SpliceAI delta 0.004.
Final determination:
Under the ClinGen TP53 Expert Panel Version 2.4 point-based framework, BA1 stand-alone benign plus BP4 and BP7 supporting scores -10 points, and a score of -7 or lower maps to Benign.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.63C>T is synonymous p.(Asp21=), with SpliceAI maximum delta 0.004 and no null or canonical splice consequence. |
cspec
pvs1_variant_assessment
spliceai
vcep_pvs1_flowchart
vcep_pvs1_splicing_worksheet
|
| PS1 | N/A | Not applicable: c.63C>T is synonymous p.Asp21=, so it creates no alternate amino-acid change eligible for the VCEP's PS1 comparison. |
cspec
PMID:20436704
PMID:32000721
PMID:18798306
|
| PS2 | Not assessed | Not assessed: no documented proband cancer phenotype or confirmed maternity, paternity, and de novo status is available for assigning PS2 points. |
cspec
vcep_table_of_lfs_cancers_and_points_for_ps2_and_pp1_code_application
|
| PS3 | N/A | Not applicable: the TP53 VCEP PS3 functional pathway covers missense variants and small in-frame deletions, whereas c.63C>T is synonymous and has no worksheet entry. |
cspec
vcep_flowchart_for_application_of_functional_rule_codes
vcep_functional_worksheet
PMID:32000721
|
| PS4 | Not assessed | Not assessed: two breast-cancer cases versus one control gave OR 2.07 (95% CI 0.18-24.15), but no VCEP-defined LFS point-qualifying phenotype was reported. |
cspec
vcep_ps4_points_table
PMID:32000721
PMID:20436704
|
| PM1 | N/A | Not applicable: p.Asp21= is synonymous at codon 21, outside the VCEP's missense PM1 codons 175, 245, 248, 249, 273, and 282. |
cspec
hotspots
|
| PM2 | Not met | Not met: gnomAD v4.1 total AF 0.000239776 exceeds the TP53 PM2 cutoff of 0.00003, with South Asian AF 0.00405103 also exceeding 0.00004. |
cspec
gnomad_v4
gnomad_v2
|
| PM3 | N/A | Not applicable: the TP53 VCEP explicitly states that PM3 does not apply to TP53/Li-Fraumeni syndrome. |
cspec
|
| PM4 | N/A | Not applicable: the VCEP marks PM4 not applicable, and synonymous p.(Asp21=) causes no protein-length change. |
cspec
pvs1_variant_assessment
|
| PM5 | N/A | Not applicable: c.63C>T is synonymous p.Asp21=, whereas every VCEP PM5 route requires a missense variant at the same amino-acid residue. |
cspec
pm5_candidates
|
| PM6 | N/A | Not applicable: the TP53 VCEP drops PM6 and requires all de novo evidence to be evaluated through PS2. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives, obligate carriers, or countable cosegregating meioses are documented for applying PP1. |
cspec
vcep_table_of_lfs_cancers_and_points_for_ps2_and_pp1_code_application
PMID:32000721
PMID:20436704
PMID:18798306
|
| PP2 | N/A | Not applicable: the TP53 VCEP explicitly designates PP2 as not applicable. |
cspec
|
| PP3 | Not met | Not met: maximum SpliceAI delta 0.004 is below the TP53 VCEP PP3 threshold of 0.2 for exonic silent splice variants. |
cspec
vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7
spliceai
vcep_pp3_bp4_codes
vcep_tp53_single_amino_acid_deletions_bayesdel_scores_1
|
| PP4 | Not assessed | Not assessed: the VCEP requires multigene-panel detection at VAF 5-35%, but no qualifying VAF or panel result is available. |
cspec
PMID:32000721
|
| PP5 | N/A | Not applicable: the TP53 VCEP explicitly prohibits use of PP5. |
cspec
|
| BA1 | Met | Met: gnomAD v4.1 South Asian FAF 0.0037098 exceeds the TP53 VCEP BA1 threshold of 0.001 in a 91,088-allele subgroup. |
cspec
gnomad_v4
|
| BS1 | Not met | Not met: South Asian gnomAD v4.1 FAF 0.0037098 is above the BS1 upper limit of 0.001 and instead meets BA1. |
cspec
gnomad_v4
|
| BS2 | Not assessed | Not assessed: one healthy female control was reported, but age, unrelatedness, single-source status, and the required count of qualifying women are unavailable. |
cspec
gnomad_v4
PMID:32000721
|
| BS3 | N/A | Not applicable: the TP53 VCEP BS3 functional pathway covers missense variants and small in-frame deletions, whereas c.63C>T is synonymous and has no worksheet entry. |
cspec
vcep_flowchart_for_application_of_functional_rule_codes
vcep_functional_worksheet
PMID:32000721
|
| BS4 | Not assessed | Not assessed: no affected family members with variant-negative testing or other family-level non-segregation evidence is documented. |
cspec
PMID:32000721
PMID:20436704
PMID:18798306
|
| BP1 | N/A | Not applicable: the TP53 VCEP excludes BP1 because truncating variants account for only a portion of disease-causing variants in these genes. |
cspec
|
| BP2 | N/A | Not applicable: the TP53 VCEP marks BP2 as not applicable, regardless of phase or co-occurrence with pathogenic variants. |
cspec
|
| BP3 | N/A | Not applicable: the VCEP marks BP3 not applicable, and synonymous p.(Asp21=) is not an in-frame deletion or insertion. |
cspec
pvs1_variant_assessment
|
| BP4 | Met | Met at supporting: maximum SpliceAI delta 0.004 is below the TP53 VCEP BP4 silent-variant threshold of 0.1. |
cspec
vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7
spliceai
vcep_pp3_bp4_codes
vcep_tp53_single_amino_acid_deletions_bayesdel_scores_1
|
| BP5 | N/A | Not applicable: the TP53 VCEP explicitly marks BP5 as not applicable. |
cspec
|
| BP6 | N/A | Not applicable: the TP53 VCEP explicitly prohibits use of BP6. |
cspec
|
| BP7 | Met | Met at supporting: synonymous c.63C>T is outside the core splice motif and has maximum SpliceAI delta 0.004, below the 0.1 threshold. |
cspec
vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7
spliceai
vcep_pp3_bp4_codes
vcep_tp53_single_amino_acid_deletions_bayesdel_scores_1
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.